Navigation Links
Rigel Will Resume Responsibility for Fostamatinib Program
Date:6/3/2013

SOUTH SAN FRANCISCO, Calif., June 4, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) and AstraZeneca AB (AZ) today announced the topline results from OSKIRA-2 and OSKIRA-3, the remaining pivotal Phase 3 clinical trials investigating fostamatinib, the first oral spleen tyrosine kinase (SYK) inhibitor in development for rheumatoid arthritis (RA). 

In the OSKIRA-2 study of patients inadequately responding to disease modifying anti-rheumatic drugs (DMARDs), fostamatinib in combination with DMARDs showed statistically significant improvements in ACR20 response rates at 24 weeks in both the 100 mg twice daily (bid) group and the group receiving 100 mg bid for four weeks followed by 150 mg once daily (qd) compared to placebo.

In the OSKIRA-3 study of patients inadequately responding to methotrexate (MTX) and a single TNF-alpha antagonist, fostamatinib in combination with MTX showed statistically significant improvements in ACR20 response rates at 24 weeks in the 100 mg bid group, but not in the group given 100 mg bid for four weeks followed by 150 mg qd compared to placebo.

Fostamatinib ACR20 Scores  OSKIRA1

OSKIRA2

OSKIRA3100 mg bid

49%, p<0.001

39.6%, p<0.001

36.2%, p=0.004100 mg bid/150 mg qd

44%, p=0.006

39.6%, p<0.001

27.8%, p=0.168Placebo

34%

24.5%

21.1%Fostamatinib continues to be well tolerated by patients. The safety findings in both the OSKIRA-2 and OSKIRA-3 studies were generally consistent with those observed in the prior OSKIRA-1 study as well as the TASKi Phase 2 program.Based on the totality of the results of the OSKIRA Phase 3 program in patients with RA, AZ has decided that it will not proceed with regulatory filings and will return the rights to the compound to Rigel.

Fostamatini
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
2. Rigel Announces First Quarter 2013 Financial Results
3. Rigel Announces Fourth Quarter and Year End 2012 Financial Results
4. Rigel Announces Participation at Two Investor Conferences
5. Rigel to Present at BIO CEO & Investor Conference
6. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
7. Rigel Announces Third Quarter 2012 Financial Results
8. Rigel to Present at UBS Global Life Sciences Conference
9. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
10. Rigel Announces Second Quarter 2012 Financial Results
11. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014   Edison Nation Medical ... a worldwide search for product ideas to improve ... Promising ideas uncovered through the 6-month search ( ... device manufacturers and healthcare retailers with whom Edison ... of individuals age 65 and older. ...
(Date:8/28/2014)... , Aug. 28, 2014  In recognition of ... health complications from the flu, pneumonia, shingles and ... have declared September to be Senior Vaccination ... age, it is important that adults ages 65 ... their vaccinations. CVS pharmacists and MinuteClinic nurse practitioners ...
(Date:8/28/2014)... Orthopaedics, the Official Joint Replacement Products of the PGA TOUR ... to golf fans at the next stop of the FedEx ... company,s fan destination – "The Stryker Mobility Zone" – will ... TPC Boston in Norton, MA starting ... the Deutsche Bank Championship, Stryker will be providing golf fans ...
Breaking Medicine Technology:Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5
(Date:8/28/2014)... 2014 (HealthDay News) -- Lack of sleep not only puts ... at increased risk for obesity, researchers warn. The study ... they were aged 16 and 21. Nearly one-fifth of them ... they were age 16, and this group was 20 percent ... who got more than eight hours of sleep per night ...
(Date:8/28/2014)... NJ Top Docs Presents Dr. Christophe ... NJ Top Doc, Dr. Christophe Oliveira, has just ... examiner for the department of transportation. Dr. Oliveira ... perform all drug testing for commercial drivers. , ... musculoskeletal disorders including disk herniations, spinal stenosis, muscle ...
(Date:8/28/2014)... In 2012, The Ben & Catherine Ivy Foundation ... brain cancer research projects at the Translational Genomics ... officially received the final regulatory approval from University ... for the trial can begin. , In the ... Trial," TGen and its clinical partners will lead ...
(Date:8/28/2014)... New York (PRWEB) August 28, 2014 ... mount in courts around the U.S., Bernstein Liebhard LLP ... is touting devices like Mirena as ideal birth control ... Daily Press, the authors of the study point out ... preventing pregnancy than other methods favored by this patient ...
(Date:8/28/2014)... August 28, 2014 BioProcess ... delivering cutting-edge information focused on the development ... an agreement with Pall Life Sciences to ... BioProcess International Awards – the most honorable ... , The awards allow the industry to ...
Breaking Medicine News(10 mins):Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 3Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 4Health News:Pall Life Sciences Signs on as Program Sponsor of the 2014 BioProcess International Awards 2Health News:Pall Life Sciences Signs on as Program Sponsor of the 2014 BioProcess International Awards 3
... , , , ... regulations take effect under the HITECH Act. HIPAA-covered entities, ... notify affected individuals, the Secretary of Health and Human Services ... information (PHI) is breached. With these new rules in ...
... Researchers have shown for the first time that patterns of ... cancer has started to spread in melanoma patients, and to ... much surgery, if any, is required and to predict the ... cancer congress, ECCO 15 ESMO 34 [1], in Berlin ...
... ... Home Training and Consulting Inc., an industry leader in Continuous Process Improvement ... Sigma Yellow Belt Course available for free. This will help thousands of ... also allow potential Lean Six Sigma Green Belt and Black Belt Candidates ...
... ... Software environment with Strategic,s validation toolkit , ... Cardiff-by-the-Sea, Calif. (PRWEB) September 23, 2009 -- Strategic Information ... solutions, today announced an expanded Alliance relationship with QAD Inc (Nasdaq: QADI), ...
... NEW YORK, Sept. 23 Grammy Award-winning singer-songwriter John Legend ... Nikki Beach Midtown for Project Sunshine,s fall fundraiser to benefit children ... 48" x 32" mixed media portrait of the singer that was ... charity. , , (Photo: ...
... , , IRVINE, Calif., Sept. ... Maggots(TM) in the United States, announced today that its Laboratory ... Limb Salvage conference in Washington, DC, from September 24 to ... the company,s Medical Maggots(TM) product (disinfected Phaenicia sericata ...
Cached Medicine News:Health News:Healthcare Breach Notification Rules Take Effect; ID Experts Offers Complimentary Tool to Measure Organizations' Breach Index 2Health News:Healthcare Breach Notification Rules Take Effect; ID Experts Offers Complimentary Tool to Measure Organizations' Breach Index 3Health News:Ultrasound can predict tumor burden and survival in melanoma patients 2Health News:Ultrasound can predict tumor burden and survival in melanoma patients 3Health News:Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 2Health News:Strategic Information Group Announces QAD Enterprise Validation Partnership 2Health News:Strategic Information Group Announces QAD Enterprise Validation Partnership 3Health News:Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 2Health News:Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 3
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: